Spark Investment Management’s Sage Therapeutics SAGE Stock Holding History

Spark Investment Management’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,200	Closed	-$276K	–	54
2020 Q4	$276K	Buy	+3,200	New	+$236K	0.23%	36
2020 Q2	–	Sell	-18,800	Closed	-$539K	–	229
2020 Q1	$539K	Buy	+18,800	New	+$1.09M	0.29%	122
2019 Q3	–	Sell	-27,900	Closed	-$5.11M	–	500
2019 Q2	$5.11M	Buy	+27,900	New	+$4.76M	0.35%	87
2019 Q1	–	Sell	-15,300	Closed	-$1.47M	–	706
2018 Q4	$1.47M	Buy	15,300 +8,300	+119%	+$950K	0.1%	253
2018 Q3	$988K	Buy	+7,000	New	+$1.08M	0.06%	382
2017 Q4	–	Sell	-69,900	Closed	-$4.35M	–	792
2017 Q3	$4.35M	Hold	69,900	–	–	0.23%	149
2017 Q2	$5.57M	Buy	69,900 +12,400	+22%	+$896K	0.34%	78
2017 Q1	$4.09M	Buy	+57,500	New	+$3.37M	0.26%	107
2016 Q3	–	Sell	-12,000	Closed	-$361K	–	878
2016 Q2	$361K	Sell	12,000 -53,500	-82%	-$1.78M	0.03%	521
2016 Q1	$2.1M	Buy	+65,500	New	+$2.31M	0.21%	156
2015 Q2	–	Sell	-7,700	Closed	-$386K	–	724
2015 Q1	$386K	Buy	7,700 +1,000	+15%	+$43K	0.05%	427
2014 Q4	$245K	Buy	+6,700	New	+$250K	0.04%	454

Other funds holding SAGE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Spark Investment Management's SAGE Position: Q1 2021 in Review

Spark Investment Management sold out of Sage Therapeutics (SAGE) in Q1 2021, closing a stake of 3,200 shares — an estimated $276K sold.

Spark Investment Management first reported a position in SAGE in Q4 2014 and held it in 12 quarters. The position peaked at $5.57M in Q2 2017. 263 funds tracked by Wall St. Rank hold SAGE as of Q1 2021.

Spark Investment Management reported no remaining Sage Therapeutics position as of Q1 2021 after selling out during the quarter.
Spark Investment Management sold 3,200 Sage Therapeutics shares in Q1 2021, an estimated $276K.
Spark Investment Management first reported a position in Sage Therapeutics in Q4 2014 and held it in 12 quarters.
Spark Investment Management's Sage Therapeutics position peaked at $5.57M in Q2 2017.
263 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2021.

Based on Spark Investment Management's 13F filing for Q1 2021, filed 13 May 2021.